单位：人民币元
                                          本报告期末        上年度期末
总资产                                    901,080,619.50    880,052,526.22
所有者权益(或股东权益)                    337,284,906.61    322,214,374.30
归属于上市公司股东的每股净资产                      2.27              2.17
                                              报告期  年初至报告期期末
归属于上市公司股东的净利润                 15,332,932.46     15,332,932.46
基本每股收益                                        0.10              0.10
全面摊薄净资产收益率(%)                             4.55              4.55
扣除非经常性损益后全面摊薄净资产收益率(%)           4.56              4.56
每股经营活动产生的现金流量净额                                        0.12 
→查看西南药业详细信息